Why the Cochrane risk of bias tool should not include funding source as a standard item
- PMID: 24575440
- PMCID: PMC10897924
- DOI: 10.1002/14651858.ED000076
Why the Cochrane risk of bias tool should not include funding source as a standard item
References
-
- Gøtzsche PC. Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Health Care. London: Radcliffe Publishing, 2013.
-
- Goldacre B. Bad Pharma. London: Fourth Estate; 2012.
-
- Gøtzsche PC. AbbVie considers harms to be commercially confidential information: sign a petition. BMJ 2013;347:f7569. doi.org/10.1136/bmj.f7569 - PubMed
-
- Cochrane Bias Methods Group. Assessing risk of bias in included studies. bmg.cochrane.org/assessing‐risk‐bias‐included‐studies (accessed on 18 December 2013)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources